Arovella Therapeutics Ltd
ALA•Health Care•Biotechnology•Last updated: Dec 25
About
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat cancer and conditions that impact the central nervous system. The company is engaged in the development of its invariant Natural Killer T (iNKT) cell therapy platform and its oral spray delivery technology. Arovella's iNKT cell therapy aims to enhance the body's immune response against cancer, while its oral spray technology is designed to improve the delivery of pharmaceutical compounds.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- ALA
Related Shares
Investor Resources
Should you buy Arovella Therapeutics Ltd right now?
While ALA looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now